Literature DB >> 14732408

The core enhancer is essential for proper timing of MyoD activation in limb buds and branchial arches.

Jennifer C J Chen1, David J Goldhamer.   

Abstract

Transgenic analyses have defined two transcriptional enhancers that regulate MyoD expression in mammals, the core enhancer and distal regulatory region; these enhancers exhibit complementary activities and together are sufficient to recapitulate MyoD expression in developing and mature skeletal muscle. The core enhancer is activated in presumptive muscle cells and determined myoblasts, suggesting an important role in initiating MyoD expression. Here, targeted mutagenesis in the mouse is used to identify necessary and redundant core enhancer functions. The core enhancer is essential for the timely initiation of MyoD expression in limb buds and branchial arches, as enhancer deletion delayed MyoD activation by 1 to 2 days in these muscle lineages. Functionally, this delay in MyoD transcription delayed the onset of muscle differentiation, as assayed by expression of the gene encoding for the early differentiation marker, Myogenin. In addition to these lineage-specific defects, a generalized, modest reduction in MyoD expression was observed in all muscle lineages and at all embryonic stages examined. Interestingly, however, a specific defect was not observed in the nascent myocytes at the medial and lateral aspects of the myotome, suggesting the existence of at least one other enhancer with this specificity. The core enhancer was also dispensable for Myf-5- and Pax-3-dependent regulation of MyoD transcription. These data demonstrate a differential requirement for core enhancer activity in muscle lineages derived from migratory precursors and suggest redundancy in cis regulatory mechanisms controlling myotomal MyoD expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732408     DOI: 10.1016/j.ydbio.2003.09.018

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  32 in total

1.  eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci.

Authors:  Kambiz Mousavi; Hossein Zare; Stefania Dell'orso; Lars Grontved; Gustavo Gutierrez-Cruz; Assia Derfoul; Gordon L Hager; Vittorio Sartorelli
Journal:  Mol Cell       Date:  2013-08-29       Impact factor: 17.970

Review 2.  Enhancer identification through comparative genomics.

Authors:  Axel Visel; James Bristow; Len A Pennacchio
Journal:  Semin Cell Dev Biol       Date:  2007-01-05       Impact factor: 7.727

3.  Musculin and TCF21 coordinate the maintenance of myogenic regulatory factor expression levels during mouse craniofacial development.

Authors:  Natalia Moncaut; Joe W Cross; Christine Siligan; Annette Keith; Kevin Taylor; Peter W J Rigby; Jaime J Carvajal
Journal:  Development       Date:  2012-03       Impact factor: 6.868

4.  MyoD-expressing progenitors are essential for skeletal myogenesis and satellite cell development.

Authors:  William M Wood; Shervin Etemad; Masakazu Yamamoto; David J Goldhamer
Journal:  Dev Biol       Date:  2013-09-17       Impact factor: 3.582

5.  Adaptive myogenesis under hypoxia.

Authors:  Zhong Yun; Qun Lin; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 6.  In search of lost time: Enhancers as modulators of timing in lymphocyte development and differentiation.

Authors:  Jonathan M Chu; Nicholas A Pease; Hao Yuan Kueh
Journal:  Immunol Rev       Date:  2021-03-18       Impact factor: 12.988

7.  MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells.

Authors:  Shuichi Watanabe; Hiroyuki Hirai; Yoko Asakura; Christopher Tastad; Mayank Verma; Charles Keller; James R Dutton; Atsushi Asakura
Journal:  Stem Cells       Date:  2011-03       Impact factor: 6.277

8.  Defective cranial skeletal development, larval lethality and haploinsufficiency in Myod mutant zebrafish.

Authors:  Yaniv Hinits; Victoria C Williams; Dylan Sweetman; Thomas M Donn; Taylur P Ma; Cecilia B Moens; Simon M Hughes
Journal:  Dev Biol       Date:  2011-07-23       Impact factor: 3.582

9.  Targeted deletion of the antisilencer/enhancer (ASE) element from intron 1 of the myelin proteolipid protein gene (Plp1) in mouse reveals that the element is dispensable for Plp1 expression in brain during development and remyelination.

Authors:  Glauber B Pereira; Fanxue Meng; Neriman T Kockara; Baoli Yang; Patricia A Wight
Journal:  J Neurochem       Date:  2012-12-21       Impact factor: 5.372

10.  Cloning and characterization of a novel MyoD enhancer-binding factor.

Authors:  Masakazu Yamamoto; Christopher D Watt; Ryan J Schmidt; Unsal Kuscuoglu; Roger L Miesfeld; David J Goldhamer
Journal:  Mech Dev       Date:  2007-07-10       Impact factor: 1.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.